Tags

Type your tag names separated by a space and hit enter

Modelling the health benefits of smoking cessation in Japan.
Tob Control. 2009 Feb; 18(1):10-7.TC

Abstract

BACKGROUND

In Japan, tobacco smoking is one of the main avoidable causes of disease and death. Although the benefits of smoking cessation for reducing disease risk and increasing longevity have been extensively documented, a relatively low proportion of Japanese smokers currently express a willingness to quit. This study attempted to quantify future reduction in the burden of smoking-attributable disease that could result from increases in smoking cessation.

METHODS

A simulation model was developed to project changes in mortality in Japan associated with increased quit attempts and use of nicotine replacement therapy (NRT) among smokers, incorporating data on smoking prevalence, cause-specific mortality rates, quitting behaviour and NRT use and effectiveness.

RESULTS

Approximately 46 000 lung cancer deaths and 56 000 cardiovascular disease deaths could be avoided over 20 years if the proportion of smokers making a quit attempt per year gradually increased to current US levels over 20 years. If each of these quit attempts were aided by NRT, the estimates of avoidable deaths would increase to 64 000 for lung cancer and 78 000 for cardiovascular disease. In this model, negligible deaths were avoided due to decreased smoking initiation over the 20-year simulation.

CONCLUSION

Smoking cessation can have measurable short-term impacts on the smoking-related mortality burden in Japan. However, to achieve these gains, tobacco control policies should focus both on increasing smokers' willingness to quit and providing the support and therapies to increase the likelihood that smoking cessation attempts will succeed.

Authors+Show Affiliations

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe Street, Room W6041, Baltimore, MD 21205, USA.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

18728096

Citation

Avila-Tang, E, et al. "Modelling the Health Benefits of Smoking Cessation in Japan." Tobacco Control, vol. 18, no. 1, 2009, pp. 10-7.
Avila-Tang E, Apelberg BJ, Yamaguchi N, et al. Modelling the health benefits of smoking cessation in Japan. Tob Control. 2009;18(1):10-7.
Avila-Tang, E., Apelberg, B. J., Yamaguchi, N., Katanoda, K., Sobue, T., & Samet, J. M. (2009). Modelling the health benefits of smoking cessation in Japan. Tobacco Control, 18(1), 10-7. https://doi.org/10.1136/tc.2007.024620
Avila-Tang E, et al. Modelling the Health Benefits of Smoking Cessation in Japan. Tob Control. 2009;18(1):10-7. PubMed PMID: 18728096.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Modelling the health benefits of smoking cessation in Japan. AU - Avila-Tang,E, AU - Apelberg,B J, AU - Yamaguchi,N, AU - Katanoda,K, AU - Sobue,T, AU - Samet,J M, Y1 - 2008/08/26/ PY - 2008/8/30/pubmed PY - 2009/11/5/medline PY - 2008/8/30/entrez SP - 10 EP - 7 JF - Tobacco control JO - Tob Control VL - 18 IS - 1 N2 - BACKGROUND: In Japan, tobacco smoking is one of the main avoidable causes of disease and death. Although the benefits of smoking cessation for reducing disease risk and increasing longevity have been extensively documented, a relatively low proportion of Japanese smokers currently express a willingness to quit. This study attempted to quantify future reduction in the burden of smoking-attributable disease that could result from increases in smoking cessation. METHODS: A simulation model was developed to project changes in mortality in Japan associated with increased quit attempts and use of nicotine replacement therapy (NRT) among smokers, incorporating data on smoking prevalence, cause-specific mortality rates, quitting behaviour and NRT use and effectiveness. RESULTS: Approximately 46 000 lung cancer deaths and 56 000 cardiovascular disease deaths could be avoided over 20 years if the proportion of smokers making a quit attempt per year gradually increased to current US levels over 20 years. If each of these quit attempts were aided by NRT, the estimates of avoidable deaths would increase to 64 000 for lung cancer and 78 000 for cardiovascular disease. In this model, negligible deaths were avoided due to decreased smoking initiation over the 20-year simulation. CONCLUSION: Smoking cessation can have measurable short-term impacts on the smoking-related mortality burden in Japan. However, to achieve these gains, tobacco control policies should focus both on increasing smokers' willingness to quit and providing the support and therapies to increase the likelihood that smoking cessation attempts will succeed. SN - 1468-3318 UR - https://www.unboundmedicine.com/medline/citation/18728096/Modelling_the_health_benefits_of_smoking_cessation_in_Japan_ L2 - https://tobaccocontrol.bmj.com/lookup/pmidlookup?view=long&pmid=18728096 DB - PRIME DP - Unbound Medicine ER -